With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
According to Eli Lilly's latest financial reports the company's current EPS (TTM) is HK$42.21. In 2022 the company made an earnings per share (EPS) of HK$53.02 an increase over its 2021 EPS that were of HK$47.04.